RecruitingNot ApplicableNCT06991270

OMNI 3.1 Surgical System in Subjects With Primary Open-Angle Glaucoma

A Pilot Study of the OMNI 3.1 Surgical System in Subjects With Primary Open-Angle Glaucoma


Sponsor

Sight Sciences, Inc.

Enrollment

25 participants

Start Date

Feb 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

To gain early evidence of safety and assess the effectiveness of the intraocular pressure (IOP)-lowering effectiveness of the OMNI 3.0 Surgical System in primary open-angel glaucoma (POAG).


Eligibility

Min Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating whether a small surgical device called the OMNI 3.1 System, used during or after cataract surgery, can safely and effectively lower eye pressure in people with mild to moderate open-angle glaucoma. **You may be eligible if...** - You are 45 or older - You have been diagnosed with mild to moderate open-angle glaucoma - Your eye pressure is at least 16 mmHg (if on eye pressure medication) or at least 21 mmHg (if unmedicated) - You are having cataract surgery, or you already had it at least 6 months ago **You may NOT be eligible if...** - You have had certain prior glaucoma procedures or surgeries - You have any type of glaucoma other than open-angle - You are using topical steroid eye drops - You have another serious eye condition such as wet macular degeneration or corneal disease Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEOMNI 3.0 Surgical System

Canaloplasty and trabeculotomy.


Locations(1)

Panama Eye Center

Panama City, Panama

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06991270


Related Trials